Literature DB >> 31294974

Mechanistic Insight on the Mode of Action of Colletoic Acid.

Taotao Ling, Darcie J Miller, Walter H Lang, Elizabeth Griffith, Adaris Rodriguez-Cortes, Ikbale El Ayachi1, Gustavo Palacios, Jaeki Min, Gustavo Miranda-Carboni1, Richard E Lee, Fatima Rivas.   

Abstract

The natural product colletoic acid (CA) is a selective inhibitor of 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1), which primarily converts cortisone to the active glucocorticoid (GC) cortisol. Here, CA's mode of action and its potential as a chemical tool to study intracellular GC signaling in adipogenesis are disclosed. 11β-HSD1 biochemical studies of CA indicated that its functional groups at C-1, C-4, and C-9 were important for enzymatic activity; an X-ray crystal structure of 11β-HSD1 bound to CA at 2.6 Å resolution revealed the nature of those interactions, namely, a close-fitting and favorable interactions between the constrained CA spirocycle and the catalytic triad of 11β-HSD1. Structure-activity relationship studies culminated in the development of a superior CA analogue with improved target engagement. Furthermore, we demonstrate that CA selectively inhibits preadipocyte differentiation through 11β-HSD1 inhibition, suppressing other relevant key drivers of adipogenesis (i.e., PPARγ, PGC-1α), presumably by negatively modulating the glucocorticoid signaling pathway. The combined findings provide an in-depth evaluation of the mode of action of CA and its potential as a tool compound to study adipose tissue and its implications in metabolic syndrome.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31294974      PMCID: PMC8688139          DOI: 10.1021/acs.jmedchem.9b00187

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  55 in total

1.  Effects of an 11β-hydroxysteroid dehydrogenase type 1 inhibitor, MK-0916, in patients with type 2 diabetes mellitus and metabolic syndrome.

Authors:  P U Feig; S Shah; A Hermanowski-Vosatka; D Plotkin; M S Springer; S Donahue; C Thach; E J Klein; E Lai; K D Kaufman
Journal:  Diabetes Obes Metab       Date:  2011-06       Impact factor: 6.577

2.  Coot: model-building tools for molecular graphics.

Authors:  Paul Emsley; Kevin Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2004-11-26

3.  Cell-based assay for screening 11beta-hydroxysteroid dehydrogenase inhibitors using liquid chromatography/tandem mass spectrometry detection.

Authors:  Rongda Xu; Bi-Ching Sang; Marc Navre; Daniel B Kassel
Journal:  Rapid Commun Mass Spectrom       Date:  2006       Impact factor: 2.419

4.  Modulation of 11beta-hydroxysteroid dehydrogenase (11betaHSD) activity biomarkers and pharmacokinetics of PF-00915275, a selective 11betaHSD1 inhibitor.

Authors:  Rachel Courtney; Paul M Stewart; Melvin Toh; Marie-Noella Ndongo; Roberto A Calle; Boaz Hirshberg
Journal:  J Clin Endocrinol Metab       Date:  2007-11-06       Impact factor: 5.958

5.  Adipocyte hypertrophy-hyperplasia balance contributes to weight loss after bariatric surgery.

Authors:  Lindsey A Muir; Nicki A Baker; Alexandra R Washabaugh; Christopher K Neeley; Carmen G Flesher; Jennifer B DelProposto; Lynn M Geletka; Amir A Ghaferi; Jonathan F Finks; Kanakadurga Singer; Oliver A Varban; Carey N Lumeng; Robert W O'Rourke
Journal:  Adipocyte       Date:  2017-01-27       Impact factor: 4.534

Review 6.  Adipokines: a treasure trove for the discovery of biomarkers for metabolic disorders.

Authors:  Stefan Lehr; Sonja Hartwig; Henrike Sell
Journal:  Proteomics Clin Appl       Date:  2011-12-27       Impact factor: 3.494

7.  PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance.

Authors:  N Kubota; Y Terauchi; H Miki; H Tamemoto; T Yamauchi; K Komeda; S Satoh; R Nakano; C Ishii; T Sugiyama; K Eto; Y Tsubamoto; A Okuno; K Murakami; H Sekihara; G Hasegawa; M Naito; Y Toyoshima; S Tanaka; K Shiota; T Kitamura; T Fujita; O Ezaki; S Aizawa; T Kadowaki
Journal:  Mol Cell       Date:  1999-10       Impact factor: 17.970

8.  Adiponectin and AdipoR1 regulate PGC-1alpha and mitochondria by Ca(2+) and AMPK/SIRT1.

Authors:  Masato Iwabu; Toshimasa Yamauchi; Miki Okada-Iwabu; Koji Sato; Tatsuro Nakagawa; Masaaki Funata; Mamiko Yamaguchi; Shigeyuki Namiki; Ryo Nakayama; Mitsuhisa Tabata; Hitomi Ogata; Naoto Kubota; Iseki Takamoto; Yukiko K Hayashi; Naoko Yamauchi; Hironori Waki; Masashi Fukayama; Ichizo Nishino; Kumpei Tokuyama; Kohjiro Ueki; Yuichi Oike; Satoshi Ishii; Kenzo Hirose; Takao Shimizu; Kazushige Touhara; Takashi Kadowaki
Journal:  Nature       Date:  2010-03-31       Impact factor: 49.962

9.  Development of ergosterol peroxide probes for cellular localisation studies.

Authors:  Taotao Ling; Walter H Lang; Michelle M Martinez-Montemayor; Fatima Rivas
Journal:  Org Biomol Chem       Date:  2019-05-29       Impact factor: 3.876

10.  Role of cdk2 in the sequential phosphorylation/activation of C/EBPbeta during adipocyte differentiation.

Authors:  Xi Li; Jae Woo Kim; Mads Grønborg; Henning Urlaub; M Daniel Lane; Qi-Qun Tang
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-29       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.